Latest ADHD Stories
Double-Blind Controlled Clinical Trial Opens Enrollment at the UCLA Semel Institute LOS ANGELES, Jan. 5, 2015 /PRNewswire/ -- NeuroSigma®, Inc.
PARIS and NEW YORK, Dec.
According to ADHD specialist Dr. Ashley Gorman, the keys to an accurate diagnosis are the extent of the symptoms and their duration.
Study from Canada Shows Rendering SPECT In 3D Makes a Significant Difference COSTA MESA, Calif., Dec.
KP415 is Designed as an Abuse-Deterrent, Controlled Release Prodrug of Methylphenidate for the Treatment of ADHD CORALVILLE, Iowa, Dec.
Improved student experience and heightened functionality just two of the many results v2.0 of neuroscientist-created ACTIVATE™ cognitive brain training program yields. New
TORONTO, Nov. 20, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), a pharmaceutical company, today announced that the U.S.
Fifty-nine percent of surveyed mothers of tween girls say they hesitated to speak to a doctor because they thought their daughters would outgrow their behavior PHILADELPHIA, Nov.
- Study successfully meets primary endpoint- Lack of sleep-related side effects supports flexible nighttime dosing platform to target control over symptoms during the morning routine-
- A person in a secondary role, specifically the second most important character (after the protagonist).